Announced
Completed
Founders Fund led a $280m round in Neuralink.
Financials
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Sources
Tags
United States
neuroscience
biotechnology company
Medical Equipment
medical devices
Acquisition
Domestic
Private
Minority
Private Equity
Venture Capital
Completed
Friendly
Single Bidder
Synopsis
Founders Fund, a venture capital firm investing in companies building revolutionary technologies, led a $280m round in Neuralink, a neurotechnology company. "We're extremely excited about this next chapter at Neuralink," Neuralink.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.